Loading clinical trials...
Loading clinical trials...
A Phase 1/1b First-in-human Study of BMS-986463 in Advanced Malignant Tumors
Conditions
Interventions
BMS-986463
Locations
17
United States
USC/Norris Comprehensive Cancer Center
Los Angeles, California, United States
Valkyrie Clinical Trials
Los Angeles, California, United States
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
Local Institution - 0045
Columbus, Ohio, United States
Local Institution - 0046
Dallas, Texas, United States
Local Institution - 0049
Houston, Texas, United States
Start Date
September 6, 2024
Primary Completion Date
December 19, 2028
Completion Date
December 19, 2028
Last Updated
April 15, 2026
NCT07361497
NCT07510724
NCT06305754
NCT05920356
NCT06128551
NCT07251582
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
855-907-3286Clinical.Trials@bms.comFirst line of the email MUST contain NCT # and Site #.
CONTACT
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions